These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31433340)

  • 41. Mirtazapine-induced restless legs syndrome treated with pramipexole.
    Makiguchi A; Nishida M; Shioda K; Suda S; Nisijima K; Kato S
    J Neuropsychiatry Clin Neurosci; 2015; 27(1):e76. PubMed ID: 25716506
    [No Abstract]   [Full Text] [Related]  

  • 42. A Subgroup Analysis of the Impact of Vortioxetine on Functional Capacity, as Measured by UPSA, in Patients with Major Depressive Disorder and Subjective Cognitive Dysfunction.
    Keefe RSE; Nomikos G; Zhong W; Christensen MC; Jacobson W
    Int J Neuropsychopharmacol; 2018 May; 21(5):442-447. PubMed ID: 29546401
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Restless legs syndrome due to interferon-alpha.
    LaRochelle JS; Karp BI
    Mov Disord; 2004 Jun; 19(6):730-1. PubMed ID: 15197722
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Restless legs and restless legs-like syndrome.
    Bassetti CL; Kretzschmar U; Werth E; Baumann CR
    Sleep Med; 2006 Sep; 7(6):534. PubMed ID: 16931148
    [No Abstract]   [Full Text] [Related]  

  • 45. Vortioxetine for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
    Citrome L
    Int J Clin Pract; 2014 Jan; 68(1):60-82. PubMed ID: 24165478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Alimemazine-induced restless legs syndrome: About two cases].
    Gonzalez C; Gras-Champel V; Masmoudi K
    Therapie; 2017 Dec; 72(6):709-710. PubMed ID: 28647108
    [No Abstract]   [Full Text] [Related]  

  • 47. Vortioxetine: A review of the pharmacology and clinical profile of the novel antidepressant.
    Sowa-Kućma M; Pańczyszyn-Trzewik P; Misztak P; Jaeschke RR; Sendek K; Styczeń K; Datka W; Koperny M
    Pharmacol Rep; 2017 Aug; 69(4):595-601. PubMed ID: 28499187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Restless Legs Syndrome and Depression: Effect Mediation by Disturbed Sleep and Periodic Limb Movements.
    Koo BB; Blackwell T; Lee HB; Stone KL; Louis ED; Redline S;
    Am J Geriatr Psychiatry; 2016 Nov; 24(11):1105-1116. PubMed ID: 27526989
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Topiramate-induced restless legs syndrome: a report of two cases.
    Romigi A; Izzi F; Placidi F; Sperli F; Cervellino A; Marciani MG
    J Neurol; 2007 Aug; 254(8):1120-1. PubMed ID: 17473947
    [No Abstract]   [Full Text] [Related]  

  • 50. Restless legs syndrome induced by quetiapine: report of seven cases and review of the literature.
    Rittmannsberger H; Werl R
    Int J Neuropsychopharmacol; 2013 Jul; 16(6):1427-31. PubMed ID: 23331473
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Periodic restless legs syndrome associated with quetiapine use: a case report.
    Pinninti NR; Mago R; Townsend J; Doghramji K
    J Clin Psychopharmacol; 2005 Dec; 25(6):617-8. PubMed ID: 16282854
    [No Abstract]   [Full Text] [Related]  

  • 52. Clozapine-associated restless legs syndrome.
    Duggal HS; Mendhekar DN
    J Clin Psychopharmacol; 2007 Feb; 27(1):89-90. PubMed ID: 17224721
    [No Abstract]   [Full Text] [Related]  

  • 53. Medication use in patients with restless legs syndrome compared with a control population.
    Pearson VE; Gamaldo CE; Allen RP; Lesage S; Hening WA; Earley CJ
    Eur J Neurol; 2008 Jan; 15(1):16-21. PubMed ID: 18005055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder.
    Mahableshwarkar AR; Jacobsen PL; Chen Y
    Curr Med Res Opin; 2013 Mar; 29(3):217-26. PubMed ID: 23252878
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lithium-aggravated nocturnal myoclonus and restless legs syndrome.
    Heiman EM; Christie M
    Am J Psychiatry; 1986 Sep; 143(9):1191-2. PubMed ID: 3752305
    [No Abstract]   [Full Text] [Related]  

  • 56. A Case of Emergent Restless Legs Syndrome With Lurasidone Therapy.
    Ghori AK; Sajatovic M; Tampi RR
    J Clin Psychopharmacol; 2016 Jun; 36(3):293-4. PubMed ID: 27035496
    [No Abstract]   [Full Text] [Related]  

  • 57. Restless legs, anxiety and caffeinism.
    Lutz EG
    J Clin Psychiatry; 1978 Sep; 39(9):693-8. PubMed ID: 690085
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of restless legs symptoms according to depressive symptoms and depression type: a cross-sectional study.
    Auvinen P; Mäntyselkä P; Koponen H; Kautiainen H; Korniloff K; Ahonen T; Vanhala M
    Nord J Psychiatry; 2018 Jan; 72(1):51-56. PubMed ID: 28990833
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The relationship with restless legs syndrome, fibromyalgia, and depressive symptoms in migraine patients.
    Akdag Uzun Z; Kurt S; Karaer Unaldi H
    Neurol Sci; 2018 Aug; 39(8):1409-1414. PubMed ID: 29777478
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of depression in patients with restless legs syndrome: what is evidence-based?
    Hornyak M; Voderholzer U; Riemann D
    Sleep Med; 2006 Apr; 7(3):301-2; author reply 303-4. PubMed ID: 16564207
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.